Cargando…

A new interventional home care model for COVID management: Virtual Covid IP

AIM: Amidst COVID-19 pandemic, the health care delivery in India faces major challenges owing to the overwhelming hospitals, exhausted healthcare workers, and shortage of crucial medical supplies such as ventilators and oxygen. The study aims to propose a novel successful interventional home care mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kesavadev, Jothydev, Basanth, Anjana, Krishnan, Gopika, Vitale, Rebecca, Parameswaran, Hari, Shijin, Sajna, R, Sreelakshmi, Raj, Sumesh, Ashik, Asha, Shankar, Arun, Badarudeen, Sameer, Raveendran, A.V., Rajalakshmy, Indu, Sanal, Geethu, Manoj, Akhila, Jose, Remya, Unes, Yaseen, Jothydev, Sunitha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Diabetes India. Published by Elsevier Ltd. 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299213/ https://www.ncbi.nlm.nih.gov/pubmed/34330071 http://dx.doi.org/10.1016/j.dsx.2021.102228

Ejemplares similares

Real-World User and Clinician Perspective and Experience with MiniMed™ 780G Advanced Hybrid Closed Loop System
por: Kesavadev, Jothydev, et al.
Publicado: (2023)

IDF21-0234 The Virtual COVID In-patient (VCIP) Care and Post Covid Symptoms: a Comparison with Conventional Care
por: Kesavadev, J., et al.
Publicado: (2022)

Management Strategies for Dealing With Surges of the COVID-19 Pandemic
por: Raveendran, A.V., et al.
Publicado: (2021)

Liraglutide therapy beyond glycemic control: an observational study in Indian patients with type 2 diabetes in real world setting
por: Kesavadev, Jothydev, et al.
Publicado: (2012)

Telemedicine for diabetes care: An Indian perspective - feasibility and efficacy
por: Kesavadev, Jothydev, et al.
Publicado: (2015)

Sitagliptin 100 mg vs glimepiride 1–3 mg as an add-on to insulin and metformin in type 2 diabetes (SWIM)
por: Kesavadev, Jothydev, et al.
Publicado: (2017)

Digital health and diabetes: experience from India
por: Kesavadev, Jothydev, et al.
Publicado: (2021)

IDF21-0236 Prevalence of Breakthrough Covid Infections and Its Severity among Vaccinated Individuals
por: Kesavadev, J., et al.
Publicado: (2022)

Evolution of Insulin Delivery Devices: From Syringes, Pens, and Pumps to DIY Artificial Pancreas
por: Kesavadev, Jothydev, et al.
Publicado: (2020)

Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Trivandrum cohort of the A(1)chieve study
por: Kesavadev, Jothydev
Publicado: (2013)

The Do-It-Yourself Artificial Pancreas: A Comprehensive Review
por: Kesavadev, Jothydev, et al.
Publicado: (2020)

Reducing the Cost of Diabetes Care with Telemedicine, Smartphone, and Home Monitoring
por: Kesavadev, Jothydev, et al.
Publicado: (2023)

Time-in-range as a target in type 2 diabetes: An urgent need
por: Saboo, Banshi, et al.
Publicado: (2021)

Human Digital Twin for Personalized Elderly Type 2 Diabetes Management
por: Thamotharan, Padmapritha, et al.
Publicado: (2023)

Sodium-glucose Cotransporter-2 Inhibitors in Combination with Other Glucose-lowering Agents for the Treatment of Type 2 Diabetes Mellitus
por: Kalra, Sanjay, et al.
Publicado: (2018)

Evolving Scope of Clinical Empathy in the Current Era of Medical Practice
por: B, Jayakrishnan, et al.
Publicado: (2023)

Steroid use during COVID-19 infection and hyperglycemia – What a physician should know
por: Sosale, Aravind, et al.
Publicado: (2021)

Blood glucose levels should be considered as a new vital sign indicative of prognosis during hospitalization
por: Kesavadev, Jothydev, et al.
Publicado: (2021)

Suggested use of vaccines in diabetes
por: Kesavadev, Jothydev, et al.
Publicado: (2012)

Understanding Patients’ Willingness to Pay for Biphasic Insulin Aspart 30/70 in a Pen Device for Type 2 Diabetes Treatment in an Out-of-Pocket Payment Market
por: Murthy, Sreenivasa, et al.
Publicado: (2021)

Health care delivery model in India with relevance to diabetes care
por: Das, Ashok Kumar, et al.
Publicado: (2022)

Challenges in Type 1 diabetes management in South East Asia: Descriptive situational assessment
por: Kesavadev, Jothydev, et al.
Publicado: (2014)

Unproven Therapies for Diabetes and Their Implications
por: Kesavadev, Jothydev, et al.
Publicado: (2016)

Expert Consensus Recommendations on Time in Range for Monitoring Glucose Levels in People with Diabetes: An Indian Perspective
por: Mohan, Viswanathan, et al.
Publicado: (2023)

Clinical Evidence and Practice-Based Guidelines on the Utility of Basal Insulin Combined Oral Therapy (Metformin and Glimepiride) in the Current Era
por: Shrivastava, Abhishek, et al.
Publicado: (2023)

Expert Opinion: Optimum Clinical Approach to Combination-Use of SGLT2i + DPP4i in the Indian Diabetes Setting
por: Chadha, Manoj, et al.
Publicado: (2022)

Insulinization in T2DM with Basal Analogues During COVID-19 Pandemic: Expert Opinion from an Indian Panel
por: Chawla, Manoj, et al.
Publicado: (2020)

One-year safety and effectiveness of insulin degludec in patients with diabetes mellitus in routine clinical practice in India—TRUST (Tresiba real-world use study)
por: Kesavadev, Jothydev, et al.
Publicado: (2022)

COVID-19 associated mucormycosis: A Descriptive Multisite Study from India
por: Gupta, Ritesh, et al.
Publicado: (2021)

Safety of Insulin Degludec/Insulin Aspart in Patients with Diabetes Mellitus over a Period of 1 Year during Routine Clinical Care in India: SMART (Study of Management of Diabetes with Ryzodeg™ Treatment)
por: Kesavadev, Jothydev, et al.
Publicado: (2021)

The SAGE study: Global observational analysis of glycaemic control, hypoglycaemia and diabetes management in T1DM
por: Renard, Eric, et al.
Publicado: (2021)

Barriers and solutions to diabetes management: An Indian perspective
por: Wangnoo, Subhash K., et al.
Publicado: (2013)

Long COVID-19: Challenges in the diagnosis and proposed diagnostic criteria
por: Raveendran, A.V.
Publicado: (2021)

COVID-19 re-infection: Diagnostic challenges and proposed diagnostic criteria
por: Raveendran, A.V.
Publicado: (2021)

Post COVID-19 Syndrome (“Long COVID”) and Diabetes: Challenges in Diagnosis and Management
por: Raveendran, A.V., et al.
Publicado: (2021)

Reverse quarantine and COVID-19
por: Raveendran, A.V., et al.
Publicado: (2020)

Long COVID: An overview
por: Raveendran, A.V., et al.
Publicado: (2021)

A Study of an Antipsychotic Prescription Pattern of Patients with Schizophrenia in a Developing Country
por: Ramadas, Smitha, et al.
Publicado: (2010)

Addendum 2: Forum for Injection Technique, India
por: Kalra, Sanjay, et al.
Publicado: (2014)

Addendum: First injection technique recommendations for patients with diabetes, Forum for Injection Techniques India
por: Kalra, Sanjay, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_b88kipul90pip5ml2a54imbjkm